is compounded semaglutide being banned FDA Warns on Certain Forms of Safe use of compounded GLP

Quick Answer: Tirzepatide may indirectly affect menstrual cycles through significant weight loss and metabolic changes that influence reproductive hormone balance, though it does not directly target menstrual function

Target: 5 mg: 7501000 mcg per injection by Weeks 512

1970 cf

Meier JJ (2021) Efficacy of semaglutide in a subcutaneous and an oral formulation

Month 3 After 12 weeks or 3 months, users experienced a 1.1% drop in HbA1c level, and fasting blood glucose levels dropped to 6.6 mmol/L from a baseline of 9.6 mmol/L

After reaching a plateau around week 40 to 44, participants maintained their weight through week 48 with minimal regain of only 0.8kg on average